Back to top
more

ETF Quote Details

Previous Close 72.20
Open 72.13
Bid 71.96
Ask 72.02
Day Low-High 71.80-72.15
52wk Low-High 55.36-72.94
Volume 13,130
NAV (month end) 72.93
Premium (+)/Discount (-) (month end)-0.73

Zacks Premium Research for IHE

Zacks ETF Rank Hold 3
ETF Risk High
ETF Research Report

Zacks proprietary quantitative models divide each set of ETFs following a similar investment strategy (style box/industry/asset class) into three risk categories- High, Medium, and Low. The aim of our models is to select the best ETFs within each risk category, so that investors can pick an ETF that matches their particular risk preference in order to better achieve their investment goals.

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

ETF Expense Ratio

Expense Ratio 0.39%
Dividend (Yield) $1.00 (1.39%)
Issuer BLACKROCK

Benchmark for IHE

DOW JONES US SELECT PHARMACEUTICAL INDEX

The Dow Jones U.S. Select Pharmaceuticals Index is free-float adjusted market capitalization-weighted index. It includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.

Fund Summary for IHE

ISHARES US PHARMACEUTICALS ETF

The iShares U.S. Pharmaceuticals ETF seeks investment results that correspond generally to the price and yield performance of Dow Jones U.S. Select Pharmaceuticals Index.